Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04998786
Title A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse." (I2D IFM2021_03)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nantes University Hospital
Age Groups: senior
Covered Countries FRA

No variant requirements are available.